Invivo Therapeutics Holdings Corp  

(Public, NASDAQ:NVIV)   Watch this stock  
Find more results for OTC:NVIV
-3.02 (-15.57%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.00 - 19.68
52 week 1.86 - 19.68
Open 19.40
Vol / Avg. 622,627.00/243,154.00
Mkt cap 419.37M
P/E     -
Div/yield     -
EPS -0.74
Shares 25.60M
Beta -5.09
Inst. own 8%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -181.90% -108.59%
Return on average equity -345.51% -195.09%
Employees 31 -
CDP Score - -


1 Kendall Sq Fl 4
CAMBRIDGE, MA 02139-1562
United States - Map
+1-617-8635524 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a medical device company engaged in developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries and also to develop its novel Neuro-Spinal Scaffold to treat acute SCI and Neuro-Scaffold Plus Stem Cells to treat chronic SCI. The Company�s Bioresorbable Polymer Scaffold Device is a bioresorbable material that will be inserted into the spinal cord at the center of the site of injury. Its Bioresorbable Hydrogels is for the controlled release of small molecules and proteins.

Officers and directors

Mark D. Perrin Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Steven F. McAllister Chief Financial Officer
Age: 56
Bio & Compensation  - Reuters
Tamara L. Joseph J.D. Senior Vice President, Chief Compliance Officer, General Counsel
Age: 51
Bio & Compensation  - Reuters
Thomas R. Ulich M.D. Chief Scientific Officer
Age: 60
Bio & Compensation  - Reuters
Lorianne K. Masuoka M.D. Chief Medical Officer
Age: 50
Bio & Compensation  - Reuters
Daniel R. Marshak Ph.D. Director
Age: 56
Bio & Compensation  - Reuters
John A. McCarthy Jr. Director
Age: 52
Bio & Compensation  - Reuters
Ann Merrifield Director
Bio & Compensation  - Reuters
Kenneth A. Di Pietro Independent Director
Age: 56
Bio & Compensation  - Reuters
Richard J. Roberts Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters